NCT05814939View on ClinicalTrials.gov

Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

May 11, 2024

Study Completion Date

May 11, 2024

Conditions
Active Ankylosing Spondylitis
Interventions
DRUG

VC005 tablets

VC005 groups repeat administration for 12 weeks

DRUG

Tofacitinib Citrate Tablets

Tofacitinib Citrate groups repeat administration for 12 weeks

DRUG

VC005 Tablets Placebo

VC005 placebo groups repeat administration for 12 weeks

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY